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These studies deal with the mechanism of pemphigus 
IgG-induced epidermal acantholysis. When normal hu-
man skin was cultured with defined medium containing 
IgG from pemphigus serum, extensive epidermal acan-
tholysis developed and heat-labile proteolytic enzyme(s) 
were recovered in the culture medium. The enzyme(s) 
displayed maximal activity at pH 6.5 when a 3H-amino 
acid-labeled, insoluble epidermal cell material was used 
as substrate. The enzyme activity increased during the 
first 3 days of culture and the appearance of maximal 
activity coincided with the time of onset of acantholysis. 
Acantholysis did not occur in control cultures incubated 
with normal IgG and the enzyme did not appear in the 
medium or in aqueous extracts of cultured tissues. The 
enzyme(s) is probably not of lysosomal origin because 
low pH-active proteases characteristic of these organ-
elles remained within the cells. The effects of puromycin 
on appearance of enzyme activity, acantholysis and cell 
viability was studied. At cytotoxic concentrations, the 
appearance of the enzyme(s) and acantholysis were pre-
vented, whereas at less toxic concentrations enzyme 
activity and acantholysis were not prevented. Because 
inhibition of protein synthetic rates by puromycin could 
not be dissociated from the cytotoxic effects, it is uncer-
tain whether enzyme appearance and acantholysis were 
dependent upon living tissue or on specific protein syn-
thesis. After pemphigus IgG was removed from the con-
ditioned medium by DEAE cellulose and affinity column 
chromatography, the remaining material contained en-
zyme activity and caused acantholysis in fresh skin ex-
plants. Similar activities were not present in normal IgG-
containing conditioned medium or unfractionated epi-
dermal extracts from normal skin. 
These data indicate that when the pemphigus IgG 
autoantibody interacts with epidermal cell surface anti-
gens, the cell responds by synthesis or activation of a 
non-IgG "pemphigus acantholysis factor" (PAF) which 
Dlay be a nonlysosomal proteolytic enzyme. It is sug-
gested that P AF causes loss of adhesion between kera-
tinocytes and ultimately produces the characteristic 
acantholytic cells of pemphigus. 
Experimental evidence has demonstrated that antiepithelial 
antibodies from pemphigus patients are capable of producing 
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acantholysis in stratified squamous epithelia [1-8]. When nor-
mal human skin [1-4] or monkey skin [5,6] is cultured in vitro 
with whole pemphigus serum, characteristic suprabasilar epi-
dermal acantholytic "lesions" develop. Schiltz and Michel [7] 
showed that it is the IgG fraction from the serum which induces 
the acantholysis and that complement is not required to pro-
duce the damage in this in vitro system. Ultrastructural studies 
have shown that the acantholysis produced in cultured human 
skin [8] or monkey skin [6] is identical to that seen in the 
patient's lesions. Initially, suprabasalar epidermal cells lose 
their attachments in nondesmosomal areas, and later the des-
mosomes disappear and the tonoftlaments become clumped in 
a perinuclear position. Hemidesmosomes remain unaffected 
and the basal cells remain attached to the basal lamina. 
In a recent study, Schiltz, Michel, and Papay [9] showed that 
when suspensions of primary human epidermal cells were in-
cubated with pemphigus IgG, protein synthesis was inhibited, 
a rapid solubilization of insoluble cellular material occurred and 
the cells were eventually killed. These effects of pemphigus 
antibody were time-, and antibody concentration-dependent. It 
was suggested that the solubilization was caused by a nonlyso-
somal proteolytic enzyme(s), maximally active at pH 6.5 in our 
assay system, which was synthesized, released or activated by 
the epidermal cell. It was proposed that this enzyme (or group 
of enzymes) causes acantholysis. For the present study we 
tested the enzyme hypothesis for pemphigus acantholysis using 
whole skin explants cultured with pemphigus IgG. Our results 
demonstrate that a non-IgG factor(s) (pemphigus acantholysis 
factor or "P AF") is synthesized by or activated in human 
epidermal cells following their interaction with the pemphigus 
antibody. This factor causes epidermal acantholysis in fresh 
skin explants, and may be the pH 6.5 active epidermal proteo-
lytic enzyme. 
MATERIALS AND METHODS 
Culture Techniques 
Clinically normal human skin obtained from surgical mastectomy 
specimens was used in these experiments. The skin was prepared as 
previously described [7] and cultured as explants which were floated 
on lens-paper rafts. The medium was Ham's F-I0 which contained 
twice the normal concentrations of amino acids and sodium pyruvate 
+ 10% heat-denatured fetal calf serum + a mixture of antibiotics/ 
antimycotics (Grand Island Biological Co) + purified IgG fractions 
from pooled normal or pemphigus serum [7]. The pemphigus sera were 
all from patients with pemphigus vulgaris. The antiepithelial antibody 
titer of the reconstituted pemphigus IgG was adjusted to 160 as deter-
mined by reaction with monkey esophagus substrate and the IgG 
protein content varied between 20 and 40 mg/ mi medium. Control 
normal IgG was prepared from sera of persons with AB blood type, and 
was adjusted to the same protein concentration as the pemphigus IgG. 
The explants were cultured at 37°C in a humid incubator containing 
95% air/5% CO2. In the experiments where enzyme activity from 
medium was assayed, complete equilibration between the explants and 
the medium was assured by gentle mixing with a Pasteur pipette prior 
to removal of the sample. In some experiments in which "pemphigus 
acantholysis factor" was obtained, the fetal calf serum was omitted 
from the medium. For these experiments, approximately 50 explants 
(3 mm x 3 mm x 0.3 mm thick) were placed on lens paper rafts and 
floa ted on 3 ml medium containing control or pemphigus IgG. After 5 
days the explants were immersed, briefly equilibrated in the medium 
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and the IgG removed using ion exchange and affinity columns as 
described below. The pH profiles of intracellular enzymes from intact 
epidermis cultured with antibodies (Fig 2) was determined as follows. 
Human skin (8 pieces, each 1 cm2 X 0.3 mm thick) was placed into a 
trypsin solution (0.4% in Simm's Ca+ + - Mg+ + -free saline) for 2 hr and 
the epidermis removed from the dermis by microdissection. The viable, 
intact epidermis was washed several times in phosphate-buffered saline 
(PBS) and cultured in F-lO medium (without fetal calf serum) contain-
ing either pemphigus IgG (antiepithelial antibody titer 160, antibody 
protein 24 mg/ml) or normallgG (24 mg/ml). After 3 days the tissues 
were rinsed in PBS, suspended in distilled water, and the soluble 
intracellular enzymes extracted by a freeze/thaw technique [9]. 
Enzyme Assay 
Epidermal proteolytic enzymes were assayed by a modification of 
the technique previously reported [9]. Insoluble 3H-amino acid labeled 
substrate, which was prepared from cultured human epidermis, was 
precipitated with trichloroacetic acid (TCA, 5% final concentration), 
resuspended and dialyzed extensively against distilled water. This sub-
strate contained 10,000-20,000 DPM and 75-100 p.g protein per 50 p.l. 
The incubation mixture contained 50 p.l of this substrate + 50 p.1 of the 
enzyme source + 50 p.l of 0.45 M phosphate buffer at the specified pH. 
After 20 hr incubation in 0.4 ml polypropylene tubes, the mixture was 
precipitated by addition of an equal volume of 10% TCA and centrifuged 
for 4 min in a Beckman 152 Microfuge. The supernatant was collected, 
diluted with distilled water to 0.5 ml, mixed with a Triton X-100-based 
aqueous scintillation fluid and the radioactivity determined in a Beck-
man LS 230 liquid scintillation counter. Background solubilization was 
determined using the appropriate medium or extraction buffer and 
these values were subtracted from the experimental values. Enzyme 
activity was expressed as DPM converted to TCA-soluble radioactivity 
during the 20-hr incubation period. 
Puromycin Studies 
For the experiment shown in Fig 4, 5-mm discs of skin (0.5-mm 
thick) were prepared from surgical specimen using a circular punch 
biopsy instrument and cultured 48 hr on rafts in the presence of 
puromycin .2HCI (0-30 P.M, Sigma Chemical Co., P-7255) . Then, to 
deplete puromycin and amino acids from the tissue, the explants were 
washed for 45 min in 3 changes of F-lO medium followed by 30 min in 
PBS. To assess the extent of inhibition of protein synthesis, triplicate 
explants which had not been cultured with puromycin were immersed 
in 1 ml F-lO labeling medium which contained 0.01 times the normal 
concentrations of amino acids + 2 p.Ci "H-amino acid mixture (New 
England Nuclear, NET-250) + various concentrations of puromycin. 
To assess epidermal cytotoxicity, explants which had been cultured 48 
hr with different puromycin concentrations were incubated with the 
labeling mixture in the absence of puromycin. The percent recovery of 
protein synthetic rate was considered to be inversely proportional to 
cytotoxicity. Following incubation with labeling medium, epidermal-
dermal separation was achieved by a heat/cold technique (3 min at 
55°C followed by immersion in PBS at 4°C) and the TCA-insoluble 
radioactive material in each layer was determined. The tissues were 
sonicated and washed 5 times in 7.5% TCA, the pellet dissolved in NCS 
tissue solubilizer (Amersham Searle) and the radioactivity determined 
in the liquid scintillation counter. 
Column Chromatography for Isolation of "Pemphigus Acantholysis 
Factor" 
Normal or pemphigus IgG was removed from the medium in which 
skin samples had been cultured (i.e., conditioned medium) in the 
following manner. The medium (6 ml) was first dialyzed against several 
changes of 0.01 M sodium phosphate buffer, pH 8.0 and then pumped 
onto a 1 cm X 14 cm column of DEAE cellulose (Whatman DE52) 
which had equilibrated in the same buffer (flow rate 20 ml/hr). After 
the bulk of the IgG had eluted, the column was stripped with 0.01 M 
sodium phosphate buffer, pH 6.0 which contained 1 M NaC!. This latter 
fraction was then dialyzed into 0.15 M sodium phosphate buffer, pH 7.2 
and applied to a 1 cm X 10 cm column of Sepharose 4B which contained 
covalently-conjugated goat antihuman IgG (Hyland Labs.). Conjuga-
tion of the goat IgG to the cyanogen bromide-activated sepharose was 
performed using standard techniques [10]. The breakthrough peak 
from this column (eluted with 0.15 M sodium phosphate buffer, pH 7.2) 
was dialyzed against distilled water, lyophilized and redissolved in 3 ml 
F-10 medium (without antibodies or fetal calf serum). This reconsti-
tuted fraction, which contained "pemphigus acantholysis factor" and a 
control fraction prepared in the identical manner from normal IgG-
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containing conditioned medium, was dialyzed against medium, sterilized 
by Millipore filtration and cultured with fresh skin explants. 
RESULTS 
Enzyme Proteases in Skin Cultures Incubated with 
Pemphigus IgG 
Skin was grown in medium containing normal or pemphigus 
IgG, and at 4 days extensive epidermal acantholysis had oc-
curred only in the culture containing pemphigus IgG (see Fig. 
8A as an example of a typical in vitro "lesion") . At this time 
the media were assayed for enzyme activity at various pH 
values. These pH profJJes (Fig 1) showed the presence of a large 
peak of activity at pH 6.5 from cultures grown in pemphigus 
IgG, whereas this activity was absent in the control medium. 
The activity from conditioned medium containing pemphigus 
IgG was heat labile since boiling reduced this activity to back-
ground levels of conditioned medium which contained normal 
IgG (Table). 
Heat lability of protease activity" 
Sample 
NormalIgG 
Normal IgG (boiled) 
Pemphigus IgG 
Pemphigus IgG (boiled) 
DPM solubilized 
±SD 
1,062 ± 142 
988 ± 60 
5,331 ± 253 
834 ± 53 
% 
Decrease 
7.0 
84 .0 
" Triplicate samples (50/-11 each) of the medium from the experiment 
shown in Fig 1 were assayed for enzyme activity at pH 6.5 with or 
without prior boiling for 15 min. 
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FIG 1. Enzyme activities in the medium of whole skin cultures after 
4 days. The medium was F-1O which contained 10% heat-denatured 
fetal calf serum and 23 mg/ml normal or pemphigus IgG, the latter at 
an anti-ICS titer of 160. Each culture contained 20 explants in 2 ml 
medium. The activity is expressed as the average DPM of substrate 
solubilized by 50 p.l medium (triplicate samples) minus that of uncul-
tured medium. Pemphigus IgG, (PIgG); Normal IgG, (NIgG). 
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It is likely that this heat-labile medium protease(s) originated 
from epidermal cells, since similar activity was recovered in 
medium from intact isolated epidermis incubated for 2 days 
with pemphigus IgG [9]. The medium pH profile of Fig 1 was 
also different from that obtained with extracts of intact epider-
mis which had cultured 2 days with normal or pemphigus IgG. 
These extracts had low pH optima typically characteristic of 
lysosomal enzymes (Fig 2) . 
Kinetics of Protease Release into the Medium 
The medium from whole skin explant cultures was examined 
daily for the unique proteolytic enzyme(s). Cumulative enzyme 
activity is shown in the upper panel of Fig 3. In the normal 
IgG-treated culture only background activity was present, and 
this did not change during the experiment. In the permphigus 
IgG-treated culture, however, enzyme accumulation increased 
for the fIrst 3 days and then remained constant. In the lower 
panel of Fig 3 the rates of appearance of enzyme activity in this 
same experiment have been plotted to stress the temporal 
relationship between enzyme activity and acantholysis. To ob-
tain these data, the cumulative activity present the previous 
day has been subtracted from the activity of a given day. 
Maximal rate of appearance occurred between 1 and 2 days, 
and this coincided with the beginning of acantholysis in this 
experiment. 
Puromycin studies. The effects of puromycin on epidermal 
protein synthesis, appearance of protease in the medium, acan-
tholysis and cell viability was studied. Explants were cultured 
48 hr in different concentrations of puromycin (without anti-
bodies) and then incubated an additional 24 hr with a 3H-amino 
acid mixture. To assess inhibition of protein synthesis, puro-
mycin was included in the labeling medium. To determine 
cytotoxic effects, excess puromycin was washed from the tissue 
(Materials and Methods) and omitted from the labeling me-
dium. The extent of recovery of synthetic rate was considered 
to be an index of cell viability. This experiment (Fig 4) clearly 
demonstrated that it was not possible to dissociate the inhibi-
tory effects of puromycin on protein synthesis from the cyto-
toxic effects, since inhibition was inversely proportional to 
recovery. 
Several concentrations of puromycin were tested to deter-
mine effects on protease appearance and acantholysis during a 
5-day culture period. Concentrations of 0.1 J.l.M, 1 J.l.M, and 10 
/-LM, which respectively inhibited protein synthesis 18%, 41% 
and 82%, did not prevent appearance of the enzyme or acan-
tholysis. The effect of 100 J.l.M puromycin on appearance of 
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FIG 2. Activity vs pH profUes of the soluble intracellular fraction 
from intact epidermis which had incubated 48 h with normal IgG or 
pemphigus IgG (Materials and Methods). 
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FIG 3. Medium enzyme activities from whole skin during a 5-day 
culture period with normal or pemphigus IgG. Pieces of human skin 
(15 per culture) were cultured with medium containing 20.3 mg/ rnl 
normal or pemphigus IgG, the latter at an anti-ICS titer of 80. Tripli-
cate, 50 ,.u samples were removed from the cultures at daily intervals, 
frozen and later assayed at pH 6.5. The zero point was removed at the 
start of the culture period. Upper panel, cumulative activity; lower 
panel, rate of change of activity (ie, the activity of a given day minus 
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FIG 4. Concentration-dependent inhibition and recovery of epider-
mal protein synthesis by puromycin. Whole skin explants were cultured 
2 days with the indicated concentrations of puromycin, and then 
incubated 24 hr with "H-amino acid mixture to assess rates of epidermal 
protein synthesis (Materials and Methods). The total TCA-insoluble 
radioactivity of the control (cultured and pulsed without puromycin) 
was 105,800 ± 9,395 DPM. 
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protease is shown in Fig 5. In cultures containing normal IgG, 
normal IgG + puromycin or pemphigus IgG + puromycin, 
protease activity did not increase significantly, and acantholysis 
did not develop in any of these three cultures. In contrast, 
cultures containing pemphigus IgG alone showed increased 
enzyme activity and acantholysis occurred. 
Recovery of Non-lgG "Pemphigus Acantholysis Factor(s)" 
from Medium of Skin Cultured with Pemphigus IgG 
The experiments shown in Fig 3 and 5 respectively demon-
strated that acantholysis and the appearance of the unique 
protease enzyme(s) are coincident, and that both can be pre-
vented by puromycin. As an approach to determine whether 
enzyme activity was responsible for acantholysis, we removed 
the IgG from the medium of skin cultured for 4 days and tested 
the remaining material for the 2 activities. The bulk of the IgG 
was removed by DEAE cellulose column chromatography (Fig 
6) . As shown previously [7], most of the IgG, but not all the 
pemphigus antibody, eluted in the void volume of this column. 
The bound fraction was eluted from this column and applied to 
an affinity column which contained goat antihuman IgG cova-
lently bound to Sepharose 4B. The breakthrough peak from 
this column (Fig 7) was collected, reconstituted in F-lD medium 
and tested for protease activity and ability to cause acantho-
lysis. This material did not contain pemphigus antibody, as 
shown by indirect immunofluorescence testing, and did not 
contain IgG, as shown by immunoelectrophoresis. This fraction 
caused suprabasilar epidermal acantholysis in fresh skin ex-
plants after 3 days in culture (Fig BE), and the histology was 
similar to that obtained with pemphigus IgG (Fig 8A). Acan-
tholysis did not occur in control medium which contained the 
affmity column breakthrough peak from normal IgG-containing 
conditioned medium (Fig 8C). The experiment shown in Fig 6-
B has been repeated 3 times using different batches of pemphi-
gus IgG conditioned medium. Non-IgG acantholysis factor(s) 
were recovered in 2 of these experiments, and the protease 
enzyme(s) was present in both. The enzyme activities were 
small, but demonstrable at the beginning of the secondary 
culture period, and after 3 days had increased nearly 4-fold. 
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FIG 6. DEAE cellulose column elution profile of 6 ml medium from 
skin explants which had cultured 4 days in F-lO medium containing 
lO% heatdenatured fetal calf serum + pemphigus IgG (Materials and 
Methods). The pemphigus antibody titer of the void volume peak was 
40 and the stripped peak was 20 (both reconstitued in 12 m.l PBS). PAb 
= pemphigus antibody; "PAF" = pemphigus acantholysis factor; SB 
= starting buffer. 
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FIG 7. Affinity column chromatography of the DEAE cellulose col-
umn stripped traction. The DEAE cellulose traction which eluted 
between 130 and 160 ml (Fig 6) was dialyzed against 0.15 M sodium 
phosphate buffer. pH 7.2 and applied to a column which contained goat 
IgG directed against human IgG. The goat IgG was covalently bound 
to Sepharose 4B (Materials and Methods). The breakthrough peak (0-
30 ml) contained a pemphigus antibody titer of zero and the citrate-
eluted peak had a titer of 10 (both in 30 mJ PBS). 
Laclz of P AF Activity in Epidermal Extracts 
Because our experiments suggested that a non-IgG pemphi-
gus acantholysis factor (P AF) originated from epidermis, we 
tested epidermal extracts from noncultured skin for ability to 
cause acantholysis in cultured skin. An epidermal extract was 
prepared [9J, added to F-lO medium (final protein concentration 
0.1 mg/ml) and the pH was adjusted to 0.5 pH increments from 
3.5 to 7.5. Following dialysis against F-IO at the appropriate pH. 
these media were cultured with fresh skin explants. Epidermal 
acantholysis was not produced in any of the pH-adjusted media. 
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FIG 8. Photomicrographs of normal human skin explan ts which had cultured 72 hr in F-lO medium containing (A) 39 mg/ ml pemphigus IgG, 
anti- leS titer 100, (b) "Pemphigus acantholysis factor" (ie. the breakthrough fraction from Fig 7) or (e) a fraction from normal IgG-containing 
conditioned medium which was prepared in parallel to the pemphigus acantholysis factor. The medium for (A) contained 10% heat-denatured 
fetal calf serum, which was omitted in (8) and (e) . Hematoxylin and eosin (x 180). 
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either in the presence or absence of the epidermal extract. 
Nonspecific epidermal changes did occur with extracts at lower 
pH values (3.5 to 5.5), and increased intracellular edema was 
prominent. 
DISCUSSION 
These experiments have demonstrated that when pemphigus 
antibody-induced epidermal acantholysis occurs in cultured 
human skin, non-IgG factor(s) appear in the medium which can 
cause acantholysis in fresh skin explants. This "pemphigus 
acantholysis factor" (P AF) originates from the skin and does 
not appear in control cultures incubated with normal IgG. 
Indirect evidence suggests that P AF may be a protease 
enzyme: (i) enzyme activity and acantholysis activity are not 
gene.rated in control cultures, (ii) during a 6-day culture period 
maXImal protease activity coincided with the time of onset of 
acantholysis, (iii) puromycin prevented both the appearance of 
the protease and acantholysis in pemphigus IgG-treated cul-
tures and (iv) both activities were present in conditioned me-
dium following removal of the pemphigus antibody. However, 
further study is needed to establish a direct cause and effect 
relationship between the 2 activities. It is possible that protease 
activity is not the cause of acantholysis but rather results from 
acantholysis. 
It is reasonable to suspect that P AF is a proteolytic enzyme. 
In previous s~udies [9], we showed that protease activity was 
released by human epidermal cells cultured with pemphigus 
IgG, and that these enzymes caused solubilization of previously 
insoluble epidermal cellular material. We believe this solubili-
zation to be equivalent to acantholysis. It is also well known 
that selected proteolytic enzymes are capable of causing epi-
dermal acantholysis, for example trypsin [11], chymotrypsin 
[12] or papain and elastase [13]. These enzymes, however, do 
not cause the exact lesion to that produced by pemphigus IgG 
or P AF. Whereas, the enzymes cause acantholysis throughout 
the epidermis, pemphigus IgG or PAF-induced acantholysis 
occurs only in the supra basilar cells, thus reproducing the 
pattern of injury seen in spontaneous pemphigus vulgaris le-
sions. 
Farb, Dykes, and Lazarus [14] showed that mouse epidermal 
cells in monolayer culture became less adherent to culture 
dishes when pemphigus serum was added to the medium. 
Because the serine protease inhibitors soybean trypsin inhibitor 
and a2-macroglobulin prevented this loss of adhesion, they 
suggested pemphigus acantholysis was caused by the release of 
a serine proteinase. Since the protease in our studies has not 
yet been isolated in pure form, we have not tested it for protease 
class. We have, however, tested soybean trypsin inhibitor for 
abiljty to prevent acantholysis in cultured human skin [15]. 
This compound, at concentrations which completely inhibited 
trypsin activity, did not prevent the pemphigus antibody from 
binding to the epidermis and did not prevent acantholysis. This 
is perhaps predictable, since pemphigus acantholysis readily 
occurs in human skin explants cultured in fresh, whole pem-
phigus serum [1-6], which contains large amounts of a'z-mac-
roglobulin and aI-antitrypsin. It is possible the conflicting re-
sults may be due to species differences. 
We do not know which epidermal cells elaborate P AF or 
from whjch intracellular structures it arises. However, the factor 
likely does not originate from lysosomes because the 10w-pH-
active proteases characteristic of these organelles were not 
recovered in the medium, but remained within the epidermal 
cells. P AF may have been synthesized by the epidermal cells in 
response to the pemphigus antibody because puromycin pre-
vented acantholysis and PAF activity was not present in epi-
dermal extracts. However, since the concentration of puromycin 
required to prevent acantholysis also appeared to be cytotoxic, 
it is not known whether acantholysis was dependent upon 
specific protein synthesis, living epidermis or both. We have 
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determined t~at I?emp?igus antibod.y-induced acantholysis 
does not occur m skm whIch had been killed by freezing (Schiltz 
unp~blish~d) . PAF synthesis in response to the antibody i~ 
pOSSIble SInce we know from autoradiographic studies that 
protein synthesis in cultured explants is not impaired during 
the initial stages of acantholysis [7]. Furthermore, loss of ca-
pacity to synthesize protein coincided with the decline in rates 
of appearance of the protease enzyme. An alternate explanation 
for the lack of P AF activity in epidermal extracts may be that 
in normal epidermis the factor is complexed with inhibitors. 
Although pemphigus acantholysis appears to be an immu-
nological phenomenon, in these in vitro studies, the process is 
unique because it does not require complement activation 
[5-9]. In this regard, there is a parallel to that which occurs in 
myasthenia gravis (reviewed by Drachman, reference 16). In 
vitro studies showed that degradation rates of the cell surface 
acetylcholine receptor protein of striated muscle cultures dou-
bled in the presence of the IgG autoantibody from these pa-
tients, and this occurred without activation of complement 
[17]. 
In summary, our studies suggest that pemphigus acantholysis 
occurs as the result of a dynamic response of the epidermal cell 
to the pemphigus antibody. We believe the epidermal response 
consists of synthesis or activation of PAF, the agent which 
causes the tissue damage. It is intriguing to consider the possi-
bility that P AF generation in epidermis may be a nonspecific 
response to injury by a variety of external agents, including 
cantharidin [18,19], staphylococcal toxin exfoliatin [20], mild 
thermal damage [21] or Herpes simplex virus [22]. All these 
agents produce acantholysis in epidermis in vitro and in vivo, 
but probably not by direct action. 
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